Post by indigodaisy on Jan 18, 2014 9:18:59 GMT -5
Saw this on YMB. Don't know much about the Sierra World Equity Review, but it gives me hope that there is light at the end of this tunnel.
sierraworldequityreview.blogspot.com/2014/01/the-early-bird-catches.html
HEADLINE: The Early Bird Catches The Worm_EXCLUSIVE_Roche Partnership With MannKind (MNKD) To Be Announced In 14 Days On Friday, January 31st Projects Sierra World Equity Review.
It is a done deal, after months of work Sierra and her team now have pinpointed Friday, January 31st as the exact date that the news that Sierra broke first is expected to be be officially announced by the parties. Despite attempts by those shorting MannKind to create fear and panic selling, Sierra believes that both Roche and MannKind are very confident that MannKind's highly promising pipeline drug Afrezza will have a positive outcome following the FDA's Endocrinologic and Metabolic Drugs Advisory Committee review of MannKind's New Drug Application (NDA) for Afrezza scheduled for April 1, 2014. Sierra and her team continue to stay on top of potentially huge market moving developments, check back for updates.
sierraworldequityreview.blogspot.com/2014/01/the-early-bird-catches.html
HEADLINE: The Early Bird Catches The Worm_EXCLUSIVE_Roche Partnership With MannKind (MNKD) To Be Announced In 14 Days On Friday, January 31st Projects Sierra World Equity Review.
It is a done deal, after months of work Sierra and her team now have pinpointed Friday, January 31st as the exact date that the news that Sierra broke first is expected to be be officially announced by the parties. Despite attempts by those shorting MannKind to create fear and panic selling, Sierra believes that both Roche and MannKind are very confident that MannKind's highly promising pipeline drug Afrezza will have a positive outcome following the FDA's Endocrinologic and Metabolic Drugs Advisory Committee review of MannKind's New Drug Application (NDA) for Afrezza scheduled for April 1, 2014. Sierra and her team continue to stay on top of potentially huge market moving developments, check back for updates.
